ReviewCureus2025
Ultrasound in Renal Cancer Screening: A Review of the Literature.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney cancer is a prevalent cancer that is often asymptomatic at early stages and is commonly incidentally diagnosed using cross-sectional imaging. This review aims to provide a comprehensive review describing the utility of ultrasound, a low-cost, safe, and widely accessible tool, as a potential method for renal cancer screening. We conducted a comprehensive literature search using PubMed and Embase and identified 177 articles pertaining to ultrasonography screening of renal cell carcinoma. Fifteen articles met the following inclusion criteria: studies that used renal ultrasonography, studies that used abdominal ultrasound, studies that found renal cancer incidentally, and studies written in English. Key findings from these studies highlighted ultrasound as an effective tool for detecting asymptomatic renal cancers and identified a need to optimize screening guidelines to minimize costs and lower overdiagnosis. Further, they showed that a screening program can particularly benefit from including patients with known risk factors including older age, male gender, smoking history, and immunosuppression. We propose integrating kidney screening into existing abdominal ultrasound screening guidelines to potentially enhance feasibility and cost-effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.